Prathima Prodduturi, M.B.B.S.
Associate Physician Diplomate
To see if Prathima Prodduturi is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Phone: 916-734-5959
UC Davis Medical Group - Rocklin
UC Davis Medical Group - Rocklin
550 West Ranch View Dr.
Rocklin, CA 95765
Philosophy of Care
Our mission is to provide comprehensive and compassionate care to our patients and their care givers. An affiliation with UC Davis, our patients receive access to many clinical trials and leading edge research. We make sure every patient receives the very best treatment possible by practicing the art and science of medicine.
Clinical Interests
Dr. Prodduturi is a general hematologist/oncologist offering care for patients with various blood disorders and cancers. She has special interests and experience in treating patients with breast cancer and lymphomas.
Division
Hematology and Oncology
Center/Program Affiliation
Medical School
M.B.B.S., Osmania Medical College, Hyderbad, India 2003
Internship
Internal Medicine, John H Stroger Jr. Hospital of Cook County, Chicago IL 2006-2007
Residency
Internal Medicine, University of North Dakota, Fargo ND 2007-2009
Fellowship
Hematology and Oncology, University of Nebraska Medical Center, Omaha NE 2009-2012
Top Accrual Cancer Care Network Clinical Trials, 2021
Planetree Physician Champion: Runner up, 2018
Clinical Skills and Scholarship Award (Best Intern) at John H Stroger Jr. Hospital of Cook County, Chicago, 2007
Graduated top of the class in medical school, 2013
Prodduturi P, Bierman PJ. Current and emerging pharmacotherapies for primary CNS lymphoma. Clin Med Insights Oncol. 2012;6:219-31. doi:10.4137/CMO.S7752. Epub 2012 May 21. PMID:22654527.
Prodduturi P, Perry AM, Aoun P, Weisenburger DD, Akhtari M. Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report. J Oncol Pharm Pract. 2012 Dec;18(4):440-4. doi:10.1177/1078155212438112. Epub 2012 Mar 7. PMID:22399151.
Prodduturi P, Armitage JO. Reduced Intensity Treatment in Early Stage Hodgkin Lymphoma. Blood Lymphatic Cancer: Targets Therapy. 2011 Nov 25;2011:23-31. doi:10.2147/BLCTT.S15565.
Nathan S, Amin A, Prodduturi P. Older Age Strongly Impacts Selection for Early Invasive Therapies in Cardiogenic Shock with Differential Patterns of 1-Year Survival Observed in Younger vs. Older Patients. Circulation. 2006 May;113(e788-e834):179.